Cargando…
Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the e...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906053/ https://www.ncbi.nlm.nih.gov/pubmed/36760370 http://dx.doi.org/10.21037/tcr-22-2890 |
_version_ | 1784883932083257344 |
---|---|
author | Lou, Yuming Jin, Shuxun Hong, Xing Hong, Zhongwu Xu, Chaoyang |
author_facet | Lou, Yuming Jin, Shuxun Hong, Xing Hong, Zhongwu Xu, Chaoyang |
author_sort | Lou, Yuming |
collection | PubMed |
description | BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the expression level and clinical significance of undifferentiated embryonic cell transcription factor 1 (UTF1) in breast cancer. METHODS: Immunohistochemistry (IHC) was used to detect the expression of UTF1 in 221 breast cancer samples. The clinical significance of UTF1 protein expression in breast cancer tissues was evaluated by combining clinicopathological parameters and UTF1 expression profile. We performed 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and clone formation assays to evaluate the effect of UTF1 on Bcap37 cell proliferation. Wound healing assay and transwell migration assay were used to evaluate the changes of cell invasion and migration ability, respectively. All experiments were performed with 3 biological replicates. Genomic differences after UTF1 overexpression were evaluated by RNA sequencing technology and the possible functions and regulatory mechanisms were elucidated. RESULTS: The findings showed that UTF1 expression level was significantly correlated with tumor size (P=0.004), but not with patient age, tumor histological stage, lymph node metastasis, as well as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki67 expression levels. Kaplan-Meier survival analysis and Cox proportional hazard model indicated that UTF1 expression was significantly associated with overall survival (OS) time of breast cancer patients. The median survival time of patients with high expression level of UTF1 was shorter compared with that of patients with low UTF1 expression level. The results of cell experiments showed that UTF1 overexpression could significantly promote the growth, proliferation, migration, and invasion of breast cancer cells. The RNA sequencing results showed that UTF1 was not only closely related to apoptosis genes, but also closely related to the nuclear factor (NF)-kappa B pathway. CONCLUSIONS: The findings of the current study indicate that UTF1 is involved in occurrence and tumor progression and is significantly associated with prognosis of breast cancer patients. |
format | Online Article Text |
id | pubmed-9906053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-99060532023-02-08 Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer Lou, Yuming Jin, Shuxun Hong, Xing Hong, Zhongwu Xu, Chaoyang Transl Cancer Res Original Article BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the expression level and clinical significance of undifferentiated embryonic cell transcription factor 1 (UTF1) in breast cancer. METHODS: Immunohistochemistry (IHC) was used to detect the expression of UTF1 in 221 breast cancer samples. The clinical significance of UTF1 protein expression in breast cancer tissues was evaluated by combining clinicopathological parameters and UTF1 expression profile. We performed 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and clone formation assays to evaluate the effect of UTF1 on Bcap37 cell proliferation. Wound healing assay and transwell migration assay were used to evaluate the changes of cell invasion and migration ability, respectively. All experiments were performed with 3 biological replicates. Genomic differences after UTF1 overexpression were evaluated by RNA sequencing technology and the possible functions and regulatory mechanisms were elucidated. RESULTS: The findings showed that UTF1 expression level was significantly correlated with tumor size (P=0.004), but not with patient age, tumor histological stage, lymph node metastasis, as well as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki67 expression levels. Kaplan-Meier survival analysis and Cox proportional hazard model indicated that UTF1 expression was significantly associated with overall survival (OS) time of breast cancer patients. The median survival time of patients with high expression level of UTF1 was shorter compared with that of patients with low UTF1 expression level. The results of cell experiments showed that UTF1 overexpression could significantly promote the growth, proliferation, migration, and invasion of breast cancer cells. The RNA sequencing results showed that UTF1 was not only closely related to apoptosis genes, but also closely related to the nuclear factor (NF)-kappa B pathway. CONCLUSIONS: The findings of the current study indicate that UTF1 is involved in occurrence and tumor progression and is significantly associated with prognosis of breast cancer patients. AME Publishing Company 2023-01-13 2023-01-30 /pmc/articles/PMC9906053/ /pubmed/36760370 http://dx.doi.org/10.21037/tcr-22-2890 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Lou, Yuming Jin, Shuxun Hong, Xing Hong, Zhongwu Xu, Chaoyang Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title | Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title_full | Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title_fullStr | Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title_full_unstemmed | Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title_short | Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
title_sort | expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906053/ https://www.ncbi.nlm.nih.gov/pubmed/36760370 http://dx.doi.org/10.21037/tcr-22-2890 |
work_keys_str_mv | AT louyuming expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer AT jinshuxun expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer AT hongxing expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer AT hongzhongwu expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer AT xuchaoyang expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer |